Skip to main content

Advertisement

Log in

A new strategy in drug design of chinese medicine: Theory, method and techniques

  • Feature Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

The research and development (R&D) process of Chinese medicine, with one notable feature, clinical application based, is significantly different from which of chemical and biological medicine, from laboratory research to clinics. Besides, compound prescription is another character. Therefore, according to different R&D theories between Chinese and Western medicine, we put forward a new strategy in drug design of Chinese medicine, which focuses on “combination-activity relationship (CAR)”, taking prescription discovery, component identification and formula optimization as three key points to identify the drugs of high efficacy and low toxicity. The method of drug design of Chinese medicine includes: new prescription discovery based on clinical data and literature information, component identification based on computing and experimental research, as well as formula optimization based on system modeling. This paper puts forward the concept, research framework and techniques of drug design of Chinese medicine, which embodies the R&D model of Chinese medicine, hoping to support the drug design of Chinese medicine theoretically and technologically.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wu JA, Ji RY. Application of QSAR in drug design. Foreign Med Sci·Pharm Sect (Chin) 1989;16(1):8–16.

    Google Scholar 

  2. Xu HY, Tang SH, Chen JX, Li DF, Chen C, Yang HJ, et al. Thinking and strategy on combination-activity relationship (CAR) of Chinese medicine based on metabonomics. World Sci Technol-Modern Chin Med (Chin) 2011;13(1):30–35.

    Google Scholar 

  3. Yang HJ, Chen JX, Tang SH, Li ZK, Zhen YS, Huang LQ, et al. New drug R&D of traditional Chinese medicine—role of data mining approaches. J Biol System 2009;17:329–347.

    Article  Google Scholar 

  4. Tang SH, Chen JX, Li G, Wu HW, Chen C, Zhang N, et al. Research on component law of Chinese patent medicine for anti-influenza and development of new recipes for antiinfluenza by unsupervised data mining methods. J Tradit Chin Med 2010;30:288–293.

    Article  PubMed  Google Scholar 

  5. Lu P, Li J, Tang SH, Chen JX, Zuo XH, Liu X, et al. Development and application of traditional Chinese medicine inheritance support system. Chin J Experim Tradit Med Formul (Chin) 2009;18(9):1–4.

    CAS  Google Scholar 

  6. Chen C, Chen JX, Wu HW, Tang SH, Li G, Yi JQ, et al. Identification of key constituents in volatile oil of Ligusticum Chuanxiong based on data mining approaches. Pharmaceut Biol 2011;49:445–455.

    Article  CAS  Google Scholar 

  7. Xu HY, Huang LQ, Lu P, Yang HJ. Modernization research thoughts of Chinese medicine based on in vivo ADME process and network pharmacology. China J Chin Mater Med (Chin) 2012;37:142–145.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hong-jun Yang  (杨洪军).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, Hj., Shen, D., Xu, Hy. et al. A new strategy in drug design of chinese medicine: Theory, method and techniques. Chin. J. Integr. Med. 18, 803–806 (2012). https://doi.org/10.1007/s11655-012-1270-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-012-1270-x

Keywords

Navigation